Mutation rates are equally identified among the other major reported mutated genes of MDS, ASXL1, RUNX1, DNMT3A, TP53 (with a frequency of more than or close to 10% each), and in EZH2 and KRAS/NRAS (with a mutation frequency of about 5%). This evidence concerns the gene EZH2 and myelodysplastic syndrome.